Naïs Prade

589 total citations
8 papers, 138 citations indexed

About

Naïs Prade is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Immunology. According to data from OpenAlex, Naïs Prade has authored 8 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 3 papers in Hematology and 3 papers in Immunology. Recurrent topics in Naïs Prade's work include Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Naïs Prade is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Naïs Prade collaborates with scholars based in France and United Kingdom. Naïs Prade's co-authors include Éric Delabesse, Jean‐Jacques Fournié, Delphine Cendron, Sébastien Dejean, Rémy Poupot, Séverine Fruchon, Mary Poupot, Frédéric Pont, J Familiadès and Bernard Ycart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and European Journal of Immunology.

In The Last Decade

Naïs Prade

8 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naïs Prade France 5 62 42 37 35 31 8 138
Vincent Leymarie France 6 88 1.4× 95 2.3× 37 1.0× 56 1.6× 40 1.3× 16 226
Cecelia Perkins United States 4 93 1.5× 37 0.9× 49 1.3× 37 1.1× 17 0.5× 11 157
Andrei Coliţă Romania 7 20 0.3× 90 2.1× 54 1.5× 31 0.9× 24 0.8× 38 153
Marie V. Coignet United States 6 33 0.5× 22 0.5× 33 0.9× 21 0.6× 36 1.2× 8 123
Agathe Debliquis France 6 39 0.6× 23 0.5× 35 0.9× 17 0.5× 11 0.4× 17 92
Diego V. Clé Brazil 9 25 0.4× 79 1.9× 53 1.4× 52 1.5× 26 0.8× 21 190
Elisabet Björklund Sweden 6 30 0.5× 88 2.1× 36 1.0× 30 0.9× 24 0.8× 6 153
Carmen Sanzo Spain 5 31 0.5× 166 4.0× 84 2.3× 48 1.4× 24 0.8× 5 211
Chiara Pavoni Italy 7 18 0.3× 56 1.3× 38 1.0× 31 0.9× 33 1.1× 18 117
Immacolata Attolico Italy 6 29 0.5× 82 2.0× 47 1.3× 27 0.8× 44 1.4× 17 146

Countries citing papers authored by Naïs Prade

Since Specialization
Citations

This map shows the geographic impact of Naïs Prade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naïs Prade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naïs Prade more than expected).

Fields of papers citing papers by Naïs Prade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naïs Prade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naïs Prade. The network helps show where Naïs Prade may publish in the future.

Co-authorship network of co-authors of Naïs Prade

This figure shows the co-authorship network connecting the top 25 collaborators of Naïs Prade. A scholar is included among the top collaborators of Naïs Prade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naïs Prade. Naïs Prade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Largeaud, Laëtitia, Naïs Prade, Christine Didier, et al.. (2025). GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome. Blood Cancer Journal. 15(1). 7–7. 2 indexed citations
2.
Largeaud, Laëtitia, Naïs Prade, Isabelle Luquet, et al.. (2023). Stem cell–like reprogramming is required for leukemia-initiating activity in B-ALL. The Journal of Experimental Medicine. 221(1). 2 indexed citations
3.
Singh, Preeti, Anastasia Resteu, Aneta Mikulášová, et al.. (2021). GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1. Blood Advances. 5(24). 5631–5635. 5 indexed citations
4.
Péron, Sophie, Nelly Rouquié, Naïs Prade, et al.. (2018). PAX5AandPAX5Bisoforms are both efficient to drive B cell differentiation. Oncotarget. 9(67). 32841–32854. 4 indexed citations
5.
Pasquet, Marlène, Nelly Rouquié, Naïs Prade, et al.. (2018). PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proceedings of the National Academy of Sciences. 115(41). 10357–10362. 18 indexed citations
6.
Cahu, Xavier, Julien Calvo, Sandrine Poglio, et al.. (2017). Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. Blood Advances. 1(20). 1760–1772. 43 indexed citations
7.
Bris, Yannick Le, Stéphanie Struski, Romain Guièze, et al.. (2016). Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first‐line chronic lymphocytic leukemia. Hematological Oncology. 35(4). 664–670. 23 indexed citations
8.
Pont, Frédéric, J Familiadès, Sébastien Dejean, et al.. (2011). The gene expression profile of phosphoantigen‐specific human γδ T lymphocytes is a blend of αβ T‐cell and NK‐cell signatures. European Journal of Immunology. 42(1). 228–240. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026